Viral vector manufacturing market to reach $21.31 billion by 2030 at 21.1% CAGR, driven by increasing prevalence of cancer and infectious diseases.
Read More
Viral vector contract development and manufacturing organization market to reach $3.01 billion by 2030 at 15.3% CAGR, driven by growing investment in gene therapy research.
Read More
Viral clearance market to reach $2.06 billion by 2030 at 16.4% CAGR, driven by rising prevalence of chronic diseases and biologics production.
Read More
Vinpocetine market to reach $20.94 billion by 2030 at 9.4% CAGR, driven by increased demand for nutraceuticals supporting brain health.
Read More
Vinca alkaloid active pharmaceutical ingredient market to reach $1.88 billion by 2030 at 7.0% CAGR, driven by rising incidence of cancer worldwide.
Read More
Vesicular monoamine transporter 2 inhibitor market to reach $2.01 billion by 2030 at 9.9% CAGR, driven by increasing prevalence of parkinson’s disease.
Read More
Venlafaxine market to reach $4.31 billion by 2030 at 4.5% CAGR, driven by rising prevalence of mental health disorders and demand for personalized medicine.
Read More
Veletri market to reach $2.07 billion by 2030 at 7.4% CAGR, driven by increasing prevalence of venous diseases and rising healthcare expenditure.
Read More
Vegetarian capsules market to reach $3.09 billion by 2030 at 11.8% CAGR, driven by increasing adoption of vegan lifestyles and plant based supplements.
Read More
Vasopressin market to reach $2.88 billion by 2030 at 12.6% CAGR, driven by growing prevalence of diabetes and expanding geriatric population.
Read More